Evidence map›Paper›PMID 35629797›Full record

ArticleMembranes2022

Removal of MS2 and fr Bacteriophages Using MgAl

Nur Sena Yüzbasi, Paweł A Krawczyk, Kamila W Domagała, Alexander Englert, Michael Burkhardt, Michael Stuer, Thomas Graule

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Nur Sena YüzbasiLaboratory for High Performance Ceramics, Empa, Swiss Federal Laboratories for Materials Science and Technology, 8600 Dübendorf, Switzerland.ORCID 0000-0002-7304-4552
Paweł A KrawczykLaboratory for High Performance Ceramics, Empa, Swiss Federal Laboratories for Materials Science and Technology, 8600 Dübendorf, Switzerland.
Kamila W DomagałaLaboratory for High Performance Ceramics, Empa, Swiss Federal Laboratories for Materials Science and Technology, 8600 Dübendorf, Switzerland.
Alexander EnglertDepartment of Water and Wastewater Treatment, Institute of Environmental and Process Engineering, Eastern Switzerland University of Applied Sciences, 8640 Rapperswil, Switzerland.
Michael BurkhardtDepartment of Water and Wastewater Treatment, Institute of Environmental and Process Engineering, Eastern Switzerland University of Applied Sciences, 8640 Rapperswil, Switzerland.ORCID 0000-0003-0399-5608
Michael StuerLaboratory for High Performance Ceramics, Empa, Swiss Federal Laboratories for Materials Science and Technology, 8600 Dübendorf, Switzerland.ORCID 0000-0002-5937-0626
Thomas GrauleLaboratory for High Performance Ceramics, Empa, Swiss Federal Laboratories for Materials Science and Technology, 8600 Dübendorf, Switzerland.ORCID 0000-0002-6004-6567
Swiss Federal Laboratories for Materials Science and Technology · CHAGH University of Krakow · PLOstschweizer Fachhochschule OST · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Point-of-use ceramic filters are one of the strategies to address problems associated with waterborne diseases to remove harmful microorganisms in water sources prior to its consumption. In this study, development of adsorption-based ceramic depth filters composed of alumina platelets was achieved using spray granulation (calcined at 800 °C). Their virus retention performance was assessed using cartridges containing granular material (4 g) with two virus surrogates: MS2 and fr bacteriophages. Both materials showed complete removal, with a 7 log

Indexed as

ceramic filtersdrinking waterfr bacteriophagegranulesMS2 bacteriophagevirus removal

Identifiers

PMID35629797
PMCPMC9145336
OpenAlexW4224979055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.